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In 2019 British plastic surgeon Ranjeet Jeevan published 
an overview of an important body of work which has 
informed and shaped reconstructive breast practice in 
the UK titled “Reconstructive utilisation and outcomes 
following mastectomy surgery in women with breast cancer 
treated in England” in the Annals of the Royal College of 
Surgeons England (1). Much of this work relates to decade 
old data in a rapidly evolving surgical field, and yet many 
of the key findings remain relevant to present day practice. 
Geographical variations in provision of breast cancer 
reconstructive services and outcomes across England 
persist (2). Patchy provision of information regarding breast 
reconstruction to patients remains and age still influences 
decisions about care (3).
Despite these challenges there has been considerable 
progress in breast and reconstructive surgical practice. 
Over the past decade reconstructive options have expanded 
along with the number of breast surgeons able to apply 
aesthetic techniques to breast cancer surgery, coined 
“oncoplastic surgeons”. The routine use of Latissimus dorsi 
flap (LD flap) based reconstruction has decreased, giving 
way to implant and acellular dermal matrix (ADM)-based 
reconstruction (4,5). Implant-ADM procedure is faster 
and technically less challenging. LD flaps are increasingly 
regarded as a salvage option (6). 
In order to identify and address challenges in breast and 
reconstructive surgery data sources should be examined. 
Some of the findings quoted in Jeevan’s paper were 
extracted from Hospital Episode Statistics (HES) data, 
described by NHS Digital as a “data warehouse” collected 
by non-clinical coders for payment and commissioning of 
UK healthcare (7). HES data rely on the completeness and 
accuracy of coding; the latter depends on clinician input 
which has hitherto been poor. A survey of over 1,000 UK 
consultants (attending physicians) in 2012 highlighted poor 
clinical engagement with coding, with only 21% of NHS 
consultants reported being involved in clinical coding (8) 
Recognising the deficiencies in HES data; Jeevan undertook 
a challenging national prospective audit on reconstruction 
including over 18,000 patients. He not only analysed 
decision-making and outcomes but very importantly patient 
reported outcomes. The approach taken in the US has 
been to create a National Surgical Quality Improvement 
Program (NSQIP) database to “measure and improve the 
quality of surgical care” (9). Ideally, future planning should 
include a British database like NSQIP.
A notable observation has been that other similar 
Western countries such as the US are outperforming 
the UK in immediate breast reconstruction (IBR) rates, 
reporting 54% in invasive cancer and 63% in DCIS. Clear 
socioeconomic and ethnic divides are also reported in an 
insurance and privately funded American system (10,11). 
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While we may expect that in the state funded British system 
these divides would not exist, Jeevan’s work has suggested 
that non-white and low socioeconomic classes are less likely 
to have IBR (12). A better understanding of why different 
populations accept or decline IBR is essential to reduce 
this disparity. The wide discrepancy in UK regional IBR 
rates (9–43%) with the low national rate of 19% in 2009 
found by Jeevan is reflective of wider NHS issues as well 
as individual clinician and patient factors. A multitude of 
factors affect the patients’ uptake of IBR, and clinicians are 
guided by their experience, skillset and unit policies. It is 
encouraging to note that the UK IBR rate has increased 
since 2009 being reported at 23.3% in 2013–2014 (13). The 
2018 NICE guidelines state that all mastectomy patients 
should be offered IBR regardless of local availability, 
unless significant comorbidities rule it out (14). The 2011 
National Mastectomy and Breast Reconstruction Audit 
found no correlation between the rate of surgeons offering 
IBR and rate of patient uptake in over 15,000 patients (15). 
Going forward improving patient access and availability of 
IBR services especially in low uptake areas is imperative to 
iron out inequalities in IBR. It is important to support and 
facilitate women wanting IBR to feel able to accept it. 
Identifying and addressing key factors contributing to 
low IBR rates in individual units is important. Reassuringly 
Kamali et al. found complication rates in IBR remain the 
same despite increasing age (16) and yet Jeevan’s study 
found increasing age reduced the likelihood of IBR being 
offered despite other factors being equal or favourable; 
suggesting possible subconscious clinician bias. In our 
practice chronological age is irrelevant. We have an aging 
population of higher socioeconomic class in Cambridge. 
A recent GIRFT (Get It Right First Time) inspection of 
our unit revealed an IBR rate for cancer of 47% with low 
complication rates in breast reconstruction at 0.7% for 
implant only and 2.4% for implant-assisted LD flap. We 
offer IBR based on physiological age and patient preference 
and it clearly does not adversely affect our outcomes. Audits 
such as the National Audit of Breast Cancer in Older 
Patients (3) allows us to face and recognize treatment bias 
where it exists and take steps to address it.
Jeevan has highlighted patient access to information as a 
key factor impacting IBR uptake. He found 65% of patients 
not taking up reconstruction reported receiving the “right 
amount” of reconstruction information versus 90% of those 
who underwent reconstruction. A fully informed patient 
is important to ensure effective shared decision making in 
breast reconstruction. The awareness of breast issues and 
the ease at which patients can access health information 
continues to expand. Popular viewing sites such as youtube.
com contain large volumes of breast surgery content (17). 
Social media can be utilised to provide IBR information, 
connect patients to resources and allow patients to be able 
to anonymously interact with other verified patients who 
have had IBR and are willing to share their experiences 
(18,19). During the initial treatment phase following the 
diagnosis of breast cancer patients are rightly focused on 
oncological aspects of treatment, and some may not wish 
to prioritise immediate reconstruction. Use of neoadjuvant 
treatments, may provide the patient with the time needed 
to make complex reconstructive decisions. Although using 
neoadjuvant therapy primarily for this purpose is a relatively 
poorly explored area, it is a concept that deserves greater 
attention for future studies. Our own study using Breast-Q 
to assess patient reported outcomes in bilateral mastectomy 
and IBR has suggested the indication for surgery either 
prophylactic, therapeutic or a combination of both affects 
the patient’s perception of experience and satisfaction with 
surgery (20).
Patient reported outcomes form an important additional 
source of information in assisting patients to make the 
best decision regarding reconstruction. In Jeevan’s work 
quality of life outcomes for flap-based reconstructions 
scored the highest for breast appearance, emotional and 
sexual wellbeing and satisfaction. Surprisingly, implant only 
reconstruction did not score any higher than mastectomy 
alone. The superiority of autologous reconstruction has 
since been confirmed by other PROM studies (21,22). The 
offer of implant versus autologous reconstruction in the 
NHS is often based on the availability of local resources 
and skill mix however, cost effectiveness and resource 
implications are also contributing factors. In our own 
tertiary centre we have observed that since introducing 
ADM into our practice, there has been an increase in 
implant-only reconstruction with consequent reductions in 
more complex and expensive autologous techniques despite 
the fact that implant-only procedures that incorporated 
ADM use had similar complication rates to those that did 
not (5).
 The findings of Jeevan regarding patient reported 
outcomes are broadly similar to those of the Memorial 
Sloan Kettering group (21,22). In 2017 Pusic et al. found 
one year after IBR that patient satisfaction in implant-based 
reconstruction with breast appearance and psychosocial 
wellbeing was equal to preoperative (pre-mastectomy) 
baseline and better than baseline in autologous flap-based 
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reconstruction (22). Santosa et al. agree that autologous free 
flap based IBR has higher patient reported outcomes than 
implant alone (21). A recent systematic review by Cordova 
et al found that breast reconstruction has led to better 
patient related outcomes than mastectomy alone (23). 
Another notable finding of Jeevan’s work was the 
national reoperation rate for invasive disease of 20% 
and for in-situ disease as 30% and its associated regional 
variation. He describes reoperations as a failure and reports 
40% of reoperations have mastectomy. Another angle for 
this data is 8–12% of all BCS patients have mastectomy. 
It is important to recognize conversion from breast 
conservation surgery (BCS) to mastectomy is not a surgical 
failure but a consequence of the oncology of the disease. 
The extent of disease in a certain proportion of patients is 
underestimated. Better imaging techniques and protocols 
can reduce the proportion of patients who have BCS when 
it proves later to be oncologically inappropriate. The 
prevention of disease underestimation in future depends 
on accurate determination of disease extent. Investment 
and engagement in radiology research will help shorten the 
patient’s journey to definitive treatment. 
Regional variations in reoperation rates are multifactorial. 
Variations in margin policies between hospitals may 
contribute to this. NICE guidelines regarding margins 
published in 2002 which were in use at the time of Jeevan’s 
study were recommending margins of 2 mm (24). Since 
then various consensus guidelines by major professional 
bodies such as the Association of Breast Surgeons in the UK 
and Society of Surgical Oncology and American Society for 
Radiation Oncology (SSO-ASTRO) have been published, 
the latest NICE guidelines advises there is not enough 
evidence to define the optimum margin somewhere between 
0–2 mm, therefore advise a personalised approach. Based on 
this, smaller margins are increasingly adopted by a number 
of breast units. The impact of this change is yet to be seen, 
although the findings of a large prospective national study 
in 2017 suggest that any gains are likely to be relatively 
modest (25).
In conclusion the many important aspects of breast and 
reconstructive surgery highlighted in Jeevan’s paper (1) 
based on decade old data remain relevant in the present. 
Although we would have expected it to be outdated now in 
2020 instead it provides us with a framework of challenges 
to address for the future decade. Our goal is to erase breast 
cancer and reconstructive healthcare inequalities, improve 
patient experience and create reliable healthcare data to help 
shape the future. The future includes collaborative clinical 
databases and registries with 100% clinician engagement, 
patient reported outcomes and systemic application of 
validated tools such as the Breast-Q, digital integration, 
social media engagement, radiological advances and good 
old-fashioned hard work. 
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